Invention Grant
- Patent Title: Use of isolated fractions of mastic gum for treating optic neuropathy
-
Application No.: US15556504Application Date: 2016-03-07
-
Publication No.: US11000562B2Publication Date: 2021-05-11
- Inventor: Zadik Hazan , Konstantin Adamsky , Andre C. B. Lucassen
- Applicant: REGENERA PHARMA LTD.
- Applicant Address: IL Ness Ziona
- Assignee: REGENERA PHARMA LTD.
- Current Assignee: REGENERA PHARMA LTD.
- Current Assignee Address: IL Ness Ziona
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- Priority: IL237621 20150308
- International Application: PCT/IL2016/050253 WO 20160307
- International Announcement: WO2016/142936 WO 20160915
- Main IPC: A61K36/22
- IPC: A61K36/22 ; A61K47/06 ; A61K47/10
Abstract:
The invention relates to therapeutic uses of isolated fractions of mastic gum for treating optic neuropathy. More particularly, the invention relates to methods of treating optic neuropathy conditions using compositions comprising isolated fractions of mastic gum.
Public/Granted literature
- US20180071351A1 USE OF ISOLATED FRACTIONS OF MASTIC GUM FOR TREATING OPTIC NEUROPATHY Public/Granted day:2018-03-15
Information query
